Tracey L McLaughlin (T L McLaughlin, Tracey McLaughlin)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Topics

Insulin Resistance

Ischemia Reperfusion Injury

Top Venues

Diabetes, obesity & metabolism

Journal of endocrinological investigation

The Journal of clinical endocrinology and metabolism

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Giovanny J Martínez-Colón, Kalani Ratnasiri, Heping Chen, Sizun J Jiang, Elizabeth Zanley, Arjun Rustagi, Renu Verma, Han Chen, Jason R Andrews, Kirsten D Mertz, Alexandar Tzankov, Dan Azagury, Jack H Boyd, Garry P Nolan, Christian M Schürch, Matthias S Matter, Catherine A Blish, Tracey L McLaughlin
SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages. Science translational medicine 14 (674) (2022)
Tracey L McLaughlin, Ingela Schnittger, Anna Nagy, Elizabeth Zanley, Yue Xu, Yanqiu Song, Koen Nieman, Jennifer A Tremmel, Damini Dey, Jack Boyd, Harold Sacks
Relationship Between Coronary Atheroma, Epicardial Adipose Tissue Inflammation, and Adipocyte Differentiation Across the Human Myocardial Bridge. Journal of the American Heart Association 10 (22) (2021)
Colleen M Craig, Helen Margaret Lawler, Clare Jung Eun Lee, Marilyn Tan, Dawn Belt Davis, Jenny Tong, Michele Glodowski, Elisa Rogowitz, Rowan Karaman, Tracey L McLaughlin, Lisa Porter
PREVENT: A Randomized, Placebo-controlled Crossover Trial of Avexitide for Treatment of Postbariatric Hypoglycemia. The Journal of clinical endocrinology and metabolism 106 (8) (2021)
M R Blum, R A Popat, A Nagy, N A Cataldo, Tracey L McLaughlin
Using metabolic markers to identify insulin resistance in premenopausal women with and without polycystic ovary syndrome. Journal of endocrinological investigation 44 (10) (2021)
Marilyn Tan, Cynthia Lamendola, Roger Luong, Tracey L McLaughlin, Colleen M Craig
Safety, efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide (exendin 9-39) for treatment of post-bariatric hypoglycaemia. Diabetes, obesity & metabolism 22 (8) (2020)
Colleen M Craig, Li-Fen Liu, Thi Nguyen, Candice Price, Justus Bingham, Tracey L McLaughlin
Efficacy and pharmacokinetics of subcutaneous exendin (9-39) in patients with post-bariatric hypoglycaemia. Diabetes, obesity & metabolism 20 (2) (2017)